Boston

Sharon Levine
Health

She’s spent decades caring for dying patients. When her mom’s time came, Covid-19 kept them apart

By Eric Boodman

Wastewater Treatment Plant
Health

Wastewater testing gains traction as a Covid-19 early warning system

By Sharon Begley

coronavirus ct scan
Biotech

A biotech company tries to retrofit a lung drug to prevent Covid-19’s after effects

By Damian Garde

Vertex Pharmaceuticals - sunset
Pharmalot

Vertex angers U.K. cystic fibrosis patients with a delay in submitting data for its newest therapy

By Ed Silverman

STAT SPOTLIGHT
Biotech

Startup Spotlight: Going after immune regulators when they cause disease instead of prevent it

By Elizabeth Cooney

blood samples in hand
Health

Hospital records hold valuable Covid-19 data. Making it usable is time-consuming work

By Rebecca Robbins

Biotech

Moderna executives have cashed out $89M in shares this year, as stock price has soared on vaccine hopes

By Damian Garde

Sanofi
Business

‘One thing cancer patients don’t generally have is time’: New cancer research leader brings urgency to Sanofi

By Elizabeth Cooney

Biotech

Vaccine experts say Moderna didn’t produce data critical to assessing Covid-19 vaccine

By Helen Branswell

MODERNA - Norwood facility
Adam's Take

Moderna carries a big-boy market valuation now, so it shouldn’t act like a biotech penny stock

By Adam Feuerstein

Atul Gawande Innovation
Business

Gawande says leaving Haven CEO job will allow him to focus on Covid-19

By Casey Ross

Aviv Regev portrait
Biotech

Prominent Broad Institute scientist leaves to lead R&D at Genentech

By Elizabeth Cooney

Something ventured illo
Something Ventured

Dyne Therapeutics and three other startups got venture funding a year ago. Will it be enough to get them through Covid-19?

By Kate Sheridan

Brigham and Women's Covid
On the Front Lines

Photos: One day inside a Boston hospital’s response to Covid-19

By Eric Boodman

remdesivir antiviral drug
Health

Doctors lambaste federal process for distributing Covid-19 drug remdesivir

By Eric Boodman and Casey Ross

3d pink brain
In the Lab

Using human brain tissue in lab dishes, researchers show herpes link to Alzheimer’s

By Sharon Begley

silhouette cv vaccine
Health

Mounting promises on Covid-19 vaccines are fueling false expectations, experts say

By Helen Branswell

Digital kidney
Biotech

Akebia’s experimental pill meets anemia, heart-safety goals in two late-stage clinical trials

By Adam Feuerstein

blue Tumor+section
In the Lab

Cellular ‘backpacks’ keep immune cells in attack mode against tumors

By Elizabeth Cooney

Robin Hodges
Health

A cancer patient reconsiders her end-of-life wishes, as Covid-19 brings mortality into sharper focus

By Eric Boodman

St. Joseph's Hospital ICU patient
Health

Doctors anticipate patient requests for experimental remdesivir before all the evidence comes in

By Elizabeth Cooney

Spinraza injection
Biotech

Biogen’s blockbuster rare disease drug could be in trouble

By Damian Garde

blood test tubes
Biotech

For the first time, a blood test helped doctors find and treat multiple types of cancer in seemingly healthy people

By Kate Sheridan

illustration of intestinal villi
In the Lab

‘GI tract outside the body’ tests how well oral drugs are absorbed

By Elizabeth Cooney

Carolyn LaVita
On the Front Lines

For respiratory therapists, a shortage of a simple tube brings a new coronavirus risk

By Eric Boodman

Biogen Cambridge
Biotech

Biogen delays Alzheimer’s drug filing to FDA, citing Covid-19, complexity of data analysis

By Adam Feuerstein

Cambridge: Biogen
Biotech

Biogen execs have been quiet since Covid-19 spread through the biotech. The silence ends Wednesday

By Adam Feuerstein

Mouse Chimera Brains schizophrenia
Health

With new data, experimental drug offers hope for new approach to treating schizophrenia

By Meghana Keshavan

Biotech

Startup TScan signs $30m deal with Novartis

By Anissa Gardizy — Boston Globe

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy